Indivior (INDV) Competitors GBX 825 -1.50 (-0.18%) (As of 08:28 AM ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsHeadlinesInsider Trades INDV vs. SOPH, HCM, ITH, GRI, SLS, ERGO, BMY, SLN, AMYT, and GPHShould you be buying Indivior stock or one of its competitors? The main competitors of Indivior include Sophos Group plc (SOPH.L) (SOPH), HUTCHMED (HCM), Ithaca Energy (ITH), Grainger (GRI), Standard Life UK Smaller Companies Trust (SLS), Ergomed (ERGO), Bloomsbury Publishing (BMY), Silence Therapeutics (SLN), Amryt Pharma (AMYT), and Global Ports (GPH). These companies are all part of the "pharmaceutical products" industry. Indivior vs. Sophos Group plc (SOPH.L) HUTCHMED Ithaca Energy Grainger Standard Life UK Smaller Companies Trust Ergomed Bloomsbury Publishing Silence Therapeutics Amryt Pharma Global Ports Indivior (LON:INDV) and Sophos Group plc (SOPH.L) (LON:SOPH) are both medical companies, but which is the better business? We will contrast the two companies based on the strength of their valuation, community ranking, risk, dividends, analyst recommendations, profitability, institutional ownership, media sentiment and earnings. Do insiders & institutionals hold more shares of INDV or SOPH? 86.0% of Indivior shares are owned by institutional investors. 3.4% of Indivior shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth. Which has preferable earnings and valuation, INDV or SOPH? Sophos Group plc (SOPH.L) has lower revenue, but higher earnings than Indivior. Indivior is trading at a lower price-to-earnings ratio than Sophos Group plc (SOPH.L), indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioIndivior£1.15B0.92-£141M-£0.80-1,031.25Sophos Group plc (SOPH.L)£726.90M4.11N/A£1.70341.41 Is INDV or SOPH more profitable? Sophos Group plc (SOPH.L) has a net margin of 0.00% compared to Indivior's net margin of -12.29%. Indivior's return on equity of 12.20% beat Sophos Group plc (SOPH.L)'s return on equity.Company Net Margins Return on Equity Return on Assets Indivior-12.29% 12.20% 2.37% Sophos Group plc (SOPH.L) N/A N/A N/A Do analysts prefer INDV or SOPH? Indivior presently has a consensus price target of GBX 1,500, indicating a potential upside of 81.82%. Given Indivior's stronger consensus rating and higher possible upside, analysts plainly believe Indivior is more favorable than Sophos Group plc (SOPH.L).Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Indivior 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00Sophos Group plc (SOPH.L) 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Does the MarketBeat Community favor INDV or SOPH? Indivior received 141 more outperform votes than Sophos Group plc (SOPH.L) when rated by MarketBeat users. Likewise, 80.40% of users gave Indivior an outperform vote while only 80.19% of users gave Sophos Group plc (SOPH.L) an outperform vote. CompanyUnderperformOutperformIndiviorOutperform Votes55880.40% Underperform Votes13619.60%Sophos Group plc (SOPH.L)Outperform Votes41780.19% Underperform Votes10319.81% Is INDV or SOPH a better dividend stock? Indivior pays an annual dividend of GBX 15 per share and has a dividend yield of 1.8%. Sophos Group plc (SOPH.L) pays an annual dividend of GBX 0.04 per share and has a dividend yield of 0.0%. Indivior pays out -1,875.0% of its earnings in the form of a dividend. Sophos Group plc (SOPH.L) pays out 2.4% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Indivior is clearly the better dividend stock, given its higher yield and lower payout ratio. Does the media prefer INDV or SOPH? In the previous week, Indivior had 1 more articles in the media than Sophos Group plc (SOPH.L). MarketBeat recorded 1 mentions for Indivior and 0 mentions for Sophos Group plc (SOPH.L). Indivior's average media sentiment score of 0.50 beat Sophos Group plc (SOPH.L)'s score of 0.00 indicating that Indivior is being referred to more favorably in the media. Company Overall Sentiment Indivior Positive Sophos Group plc (SOPH.L) Neutral SummaryIndivior beats Sophos Group plc (SOPH.L) on 14 of the 18 factors compared between the two stocks. Ad Crypto 101 MediaTop "Sleeping Giant" Crypto In The Market NowTop "Sleeping Giant" Crypto In The Market Now We're looking at potential returns that could rewrite your financial future. Click here to discover our #1 crypto pick before it's too late Get Indivior News Delivered to You Automatically Sign up to receive the latest news and ratings for INDV and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart INDV vs. The Competition Export to ExcelMetricIndiviorDrug Manufacturers IndustryMedical SectorLON ExchangeMarket Cap£1.06B£1.17B£5.07B£1.39BDividend Yield4.48%3.13%4.99%11.73%P/E Ratio-1,031.25110.1883.571,549.53Price / Sales0.921,847.651,220.30209,150.30Price / Cash2.6810.4339.4632.93Price / Book-9.173.116.932.80Net Income-£141M£159.31M£119.12M£152.70M7 Day Performance4.43%-1.13%-1.83%-0.55%1 Month Performance28.40%-3.86%-3.64%7.05%1 Year Performance-38.71%87.64%31.64%91.75% Indivior Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)INDVIndivior2.1311 of 5 starsGBX 825-0.2%GBX 1,500+81.8%-38.8%£1.06B£1.15B-1,031.251,000SOPHSophos Group plc (SOPH.L)N/AGBX 580.40+1.0%N/A+0.0%£2.99B£726.90M341.41520HCMHUTCHMEDN/AGBX 278-2.1%N/A-4.7%£2.38B£610.81M-7,100.001,760Positive NewsITHIthaca EnergyN/AGBX 105.60+5.8%N/A-35.6%£1.74B£1.91B885.00220Gap UpHigh Trading VolumeGRIGrainger1.7958 of 5 starsGBX 231+4.1%GBX 299+29.4%-14.0%£1.71B£270.30M8,183.33372Gap UpSLSStandard Life UK Smaller Companies TrustN/AGBX 732-1.3%N/A+0.0%£715.41M£222.48M3.3710ERGOErgomedN/AGBX 1,346flatN/AN/A£701.00M£152.09M4,641.386BMYBloomsbury Publishing2.5042 of 5 starsGBX 648-0.9%GBX 825+27.3%+57.2%£527.73M£342.65M1,676.9234,300Positive NewsSLNSilence TherapeuticsN/AGBX 535-0.9%N/AN/A£480.35M£11.35M-11.01100High Trading VolumeAMYTAmryt PharmaN/AGBX 143-11.7%N/A+0.0%£457.11M£210.24M-4.33290Gap DownGPHGlobal PortsN/AGBX 300-4.5%N/A+8.3%£231.21M£193.58M30,000.0020 Related Companies and Tools Related Companies Sophos Group plc (SOPH.L) Alternatives HUTCHMED Alternatives Ithaca Energy Alternatives Grainger Alternatives Standard Life UK Smaller Companies Trust Alternatives Ergomed Alternatives Bloomsbury Publishing Alternatives Silence Therapeutics Alternatives Amryt Pharma Alternatives Global Ports Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (LON:INDV) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Indivior PLC Please log in to your account or sign up in order to add this asset to your watchlist. Share Indivior With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
